Dietary Resveratrol Makes Little Difference to Health
Resveratrol consumption failed to correlate with heart disease, inflammation, cancer, or even mortality in a community-based study. Are its benefits overstated?
294 RESULTS
Sort By:
Resveratrol consumption failed to correlate with heart disease, inflammation, cancer, or even mortality in a community-based study. Are its benefits overstated?
New NIH policies will require researchers to study male and female biology.
Will an antibody signature make for a new Alzheimer’s diagnostic?
Mesulam Awarded Potamkin Prize Three’s Company: Florbetaben Approved, Excludes AD Diagnosis PET Tracers Enlighten at Neurology Conference Blood Patterns: Prowling for Alzheimer’s Clues in Plasma Tau imaging of patients with different kinds of dementia and
By paring back calcium signaling, researchers prevented signs of Alzheimer’s in mice carrying a presenilin mutation. Could the strategy work in humans?
MetLife rewards research on secretases, toxic Aβ transmission.
New twist to fluorescence-based microscopy lets scientists see up-close how Aβ aggregates in living cells.
A candidate reference method for measuring Aβ42 in cerebrospinal fluid brings researchers closer to standardization.
Playing nursemaid, TGF-β helps new neurons in the brain survive, develop, and migrate.
In award-winning documentary, son traces his mother’s progression into Alzheimer’s disease.
A close-up of the protein mayhem within the synaptic bouton offers scientists an unprecedented glimpse of the activity inside.
Big-data project takes on Alzheimer's with a biomarker computational challenge.
The ADCS–PACC, a new cognitive composite test to be used in the A4 prevention trial, detects subtle deficits in older adults with brain amyloid.
AFFiRiS AG claims that a placebo formulation, not their active Aβ vaccine, slowed the progression of Alzheimer's disease in a Phase 2 study.
Researchers link frontotemporal dementia pathology to DNA damage.